Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 112,550

Sort by:

Global Medical Rubber Stopper Market Research Report 2012-2024

US$ 1,960.00

... global Medical Rubber Stopper market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment, and project the market ... market. Products mentioned as follows: Oral Liquid Stopper Syringe Stopper Freeze-dried Rubber Stopper Others Leading vendors in the market ...

January 2019 85 pages

Global Membrane Oxygenator Market Research Report 2012-2024

US$ 1,800.00

... global Membrane Oxygenator market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment, and project the market ... market. Products mentioned as follows: Silicon Membrane Oxygenator Hole Polypropylene Membrane Oxygenator Leading vendors in the market ...

January 2019 74 pages

Global Micro-CT Scanner Market Research Report 2012-2024

US$ 1,800.00

... global Micro-CT Scanner market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment, and project the market ... , the report describes major application share of regional market. Application mentioned as follows: Biological Application Industrial Application ...

January 2019 82 pages

Global Micro-Pump Market Research Report 2012-2024

US$ 1,800.00

... global Micro-Pump market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment, and project the market ... Application, the report describes major application share of regional market. Application mentioned as follows: Pharmaceutical Medical Devices In-Vitro ...

January 2019 78 pages

2019 Future of Acromegaly R&D Pipeline Drugs and Companies- Analysis of Global Acromegaly Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Acromegaly Report Description The H1 2019 pipeline review report on Acromegaly pipeline is a comprehensive study on the candidates in development ...

January 2019 65 pages

2019 Future of Actinic (Solar) Keratosis R&D Pipeline Drugs and Companies- Analysis of Global Actinic (Solar) Keratosis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Actinic (Solar) Keratosis Report Description The H1 2019 pipeline review report on Actinic (Solar) Keratosis pipeline is a comprehensive ... detailed analysis on all active Actinic (Solar) Keratosis pipeline compounds. The Actinic (Solar) Keratosis pipeline guide presents information ...

January 2019 50 pages

2019 Future of Angina/Angina Pectoris R&D Pipeline Drugs and Companies- Analysis of Global Angina (Angina Pectoris) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... some of the Angina (Angina Pectoris) pipeline companies from advancing their products into Phase 3 or Phase 4. Angina (Angina Pectoris) Report Description The H1 2019 pipeline review report on Angina (Angina Pectoris) pipeline ...

January 2019 75 pages

2019 Future of Arrhythmias R&D Pipeline Drugs and Companies- Analysis of Global Arrhythmias Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Arrhythmias Report Description The H1 2019 pipeline review report on Arrhythmias pipeline is a comprehensive study on the candidates in development ...

January 2019 50 pages

2019 Future of Arterial Thrombosis R&D Pipeline Drugs and Companies- Analysis of Global Arterial Thrombosis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Arterial Thrombosis Report Description The H1 2019 pipeline review report on Arterial Thrombosis pipeline is a comprehensive study on ... and actionable insights. Scope of Arterial Thrombosis pipeline report includes An overview of Arterial Thrombosis disease including symptoms, causes, ...

January 2019 60 pages

2019 Future of Atrial Fibrillation R&D Pipeline Drugs and Companies- Analysis of Global Atrial Fibrillation Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Atrial Fibrillation Report Description The H1 2019 pipeline review report on Atrial Fibrillation pipeline is a comprehensive study on ... and actionable insights. Scope of Atrial Fibrillation pipeline report includes An overview of Atrial Fibrillation disease including symptoms, causes, ...

January 2019 85 pages

2019 Future of Axillary Hyperhidrosis R&D Pipeline Drugs and Companies- Analysis of Global Axillary Hyperhidrosis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Axillary Hyperhidrosis Report Description The H1 2019 pipeline review report on Axillary Hyperhidrosis pipeline is a comprehensive study ... insights. Scope of Axillary Hyperhidrosis pipeline report includes An overview of Axillary Hyperhidrosis disease including symptoms, causes ...

January 2019 45 pages

2019 Future of Behcet Disease R&D Pipeline Drugs and Companies- Analysis of Global Behcet Disease Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Behcet Disease Report Description The H1 2019 pipeline review report on Behcet Disease pipeline is a comprehensive study on ... and actionable insights. Scope of Behcet Disease pipeline report includes An overview of Behcet Disease disease including symptoms, causes, diagnosis ...

January 2019 60 pages

2019 Future of Bullous Pemphigoid R&D Pipeline Drugs and Companies- Analysis of Global Bullous Pemphigoid Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Bullous Pemphigoid Report Description The H1 2019 pipeline review report on Bullous Pemphigoid pipeline is a comprehensive study on ... and actionable insights. Scope of Bullous Pemphigoid pipeline report includes An overview of Bullous Pemphigoid disease including symptoms, causes, ...

January 2019 60 pages

2019 Future of Burns R&D Pipeline Drugs and Companies- Analysis of Global Burns Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... of the Burns pipeline companies from advancing their products into Phase 3 or Phase 4. Burns Report Description The H1 2019 pipeline review ... report on Burns pipeline is a comprehensive study on the candidates ...

January 2019 75 pages

2019 Future of Chronic Urticaria/Hives R&D Pipeline Drugs and Companies- Analysis of Global Chronic Urticaria Or Hives Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... of the Chronic Urticaria Or Hives pipeline companies from advancing their products into Phase 3 or Phase 4. Chronic Urticaria Or Hives Report Description The H1 2019 pipeline review report on Chronic Urticaria Or Hives pipeline is a comprehensive ...

January 2019 65 pages

2019 Future of Contact Dermatitis R&D Pipeline Drugs and Companies- Analysis of Global Contact Dermatitis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Contact Dermatitis Report Description The H1 2019 pipeline review report on Contact Dermatitis pipeline is a comprehensive study on ... and actionable insights. Scope of Contact Dermatitis pipeline report includes An overview of Contact Dermatitis disease including symptoms, causes, ...

January 2019 40 pages

2019 Future of Coronary Artery Disease (CAD)/Ischemic Heart Disease R&D Pipeline Drugs and Companies- Analysis of Global Coronary Artery Disease (CAD) (Ischemic Heart Disease) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... 3 or Phase 4. Coronary Artery Disease (CAD) (Ischemic Heart Disease) Report Description The H1 2019 pipeline review report on Coronary Artery Disease (CAD) ( ... originating companies, license providers and universities participating in the Coronary Artery Disease (CAD) (Ischemic Heart Disease) product pipeline ...

January 2019 120 pages

2019 Future of Critical Limb Ischemia R&D Pipeline Drugs and Companies- Analysis of Global Critical Limb Ischemia Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Critical Limb Ischemia Report Description The H1 2019 pipeline review report on Critical Limb Ischemia pipeline is a comprehensive study ... presents detailed analysis on all active Critical Limb Ischemia pipeline compounds. The Critical Limb Ischemia pipeline guide presents information ...

January 2019 100 pages

2019 Future of Deep Vein Thrombosis (DVT) R&D Pipeline Drugs and Companies- Analysis of Global Deep Vein Thrombosis (DVT) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Deep Vein Thrombosis (DVT) Report Description The H1 2019 pipeline review report on Deep Vein Thrombosis (DVT) pipeline is a comprehensive study ...

January 2019 40 pages

2019 Future of Dilated Cardiomyopathy R&D Pipeline Drugs and Companies- Analysis of Global Dilated Cardiomyopathy Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Dilated Cardiomyopathy Report Description The H1 2019 pipeline review report on Dilated Cardiomyopathy pipeline is a comprehensive study ... insights. Scope of Dilated Cardiomyopathy pipeline report includes An overview of Dilated Cardiomyopathy disease including symptoms, causes ...

January 2019 60 pages

2019 Future of Epidermolysis Bullosa R&D Pipeline Drugs and Companies- Analysis of Global Epidermolysis Bullosa Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Epidermolysis Bullosa Report Description The H1 2019 pipeline review report on Epidermolysis Bullosa pipeline is a comprehensive study on ... actionable insights. Scope of Epidermolysis Bullosa pipeline report includes An overview of Epidermolysis Bullosa disease including symptoms, causes ...

January 2019 90 pages

2019 Future of Graves Diseases R&D Pipeline Drugs and Companies- Analysis of Global Graves Diseases Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Graves Diseases Report Description The H1 2019 pipeline review report on Graves Diseases pipeline is a comprehensive study on ... and actionable insights. Scope of Graves Diseases pipeline report includes An overview of Graves Diseases disease including symptoms, causes, diagnosis ...

January 2019 40 pages

2019 Future of Hidradenitis Suppurativa R&D Pipeline Drugs and Companies- Analysis of Global Hidradenitis Suppurativa Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Hidradenitis Suppurativa Report Description The H1 2019 pipeline review report on Hidradenitis Suppurativa pipeline is a comprehensive study on the candidates in development ...

January 2019 85 pages

2019 Future of Hypertrophic Cardiomyopathy R&D Pipeline Drugs and Companies- Analysis of Global Hypertrophic Cardiomyopathy Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Hypertrophic Cardiomyopathy Report Description The H1 2019 pipeline review report on Hypertrophic Cardiomyopathy pipeline is a comprehensive study on the candidates in development ...

January 2019 60 pages

2019 Future of Hypoparathyroidism R&D Pipeline Drugs and Companies- Analysis of Global Hypoparathyroidism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Hypoparathyroidism Report Description The H1 2019 pipeline review report on Hypoparathyroidism pipeline is a comprehensive study on the candidates in development ...

January 2019 40 pages

2019 Future of Hypotension R&D Pipeline Drugs and Companies- Analysis of Global Hypotension Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Hypotension Report Description The H1 2019 pipeline review report on Hypotension pipeline is a comprehensive study on the candidates in development ...

January 2019 50 pages

2019 Future of Hypothyroidism R&D Pipeline Drugs and Companies- Analysis of Global Hypothyroidism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Hypothyroidism Report Description The H1 2019 pipeline review report on Hypothyroidism pipeline is a comprehensive study on the candidates in development ...

January 2019 35 pages

2019 Future of Intermittent Claudication R&D Pipeline Drugs and Companies- Analysis of Global Intermittent Claudication Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Intermittent Claudication Report Description The H1 2019 pipeline review report on Intermittent Claudication pipeline is a comprehensive study on the candidates in development ...

January 2019 55 pages

2019 Future of Ischemia Reperfusion Injury R&D Pipeline Drugs and Companies- Analysis of Global Ischemia Reperfusion Injury Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... Phase 3 or Phase 4. Ischemia Reperfusion Injury Report Description The H1 2019 pipeline review report on Ischemia Reperfusion Injury pipeline is a comprehensive ... detailed analysis on all active Ischemia Reperfusion Injury pipeline compounds. The Ischemia Reperfusion Injury pipeline guide presents information ...

January 2019 100 pages

2019 Future of Keloids R&D Pipeline Drugs and Companies- Analysis of Global Keloids Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... of the Keloids pipeline companies from advancing their products into Phase 3 or Phase 4. Keloids Report Description The H1 2019 pipeline review ... report on Keloids pipeline is a comprehensive study on the candidates ...

January 2019 40 pages

2019 Future of Left Ventricular Dysfunction R&D Pipeline Drugs and Companies- Analysis of Global Left Ventricular Dysfunction Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... Phase 3 or Phase 4. Left Ventricular Dysfunction Report Description The H1 2019 pipeline review report on Left Ventricular Dysfunction pipeline is a comprehensive ... detailed analysis on all active Left Ventricular Dysfunction pipeline compounds. The Left Ventricular Dysfunction pipeline guide presents ...

January 2019 50 pages

2019 Future of Meniere Disease R&D Pipeline Drugs and Companies- Analysis of Global Meniere Disease Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Meniere Disease Report Description The H1 2019 pipeline review report on Meniere Disease pipeline is a comprehensive study on ... and actionable insights. Scope of Meniere Disease pipeline report includes An overview of Meniere Disease disease including symptoms, causes, diagnosis ...

January 2019 45 pages

2019 Future of Microscopic Polyangiitis (MPA) R&D Pipeline Drugs and Companies- Analysis of Global Microscopic Polyangiitis (MPA) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Microscopic Polyangiitis (MPA) Report Description The H1 2019 pipeline review report on Microscopic Polyangiitis (MPA) pipeline is a ... detailed analysis on all active Microscopic Polyangiitis (MPA) pipeline compounds. The Microscopic Polyangiitis (MPA) pipeline guide presents ...

January 2019 45 pages

2019 Future of Myocardial Fibrosis R&D Pipeline Drugs and Companies- Analysis of Global Myocardial Fibrosis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Myocardial Fibrosis Report Description The H1 2019 pipeline review report on Myocardial Fibrosis pipeline is a comprehensive study on ... and actionable insights. Scope of Myocardial Fibrosis pipeline report includes An overview of Myocardial Fibrosis disease including symptoms, causes, ...

January 2019 75 pages

2019 Future of Myocardial Ischemia R&D Pipeline Drugs and Companies- Analysis of Global Myocardial Ischemia Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Myocardial Ischemia Report Description The H1 2019 pipeline review report on Myocardial Ischemia pipeline is a comprehensive study on ... and actionable insights. Scope of Myocardial Ischemia pipeline report includes An overview of Myocardial Ischemia disease including symptoms, causes, ...

January 2019 60 pages

2019 Future of Myocarditis R&D Pipeline Drugs and Companies- Analysis of Global Myocarditis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Myocarditis Report Description The H1 2019 pipeline review report on Myocarditis pipeline is a comprehensive study on the candidates in development ...

January 2019 40 pages

2019 Future of Nasal Polyps R&D Pipeline Drugs and Companies- Analysis of Global Nasal Polyps Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Nasal Polyps Report Description The H1 2019 pipeline review report on Nasal Polyps pipeline is a comprehensive study on the ... clear and actionable insights. Scope of Nasal Polyps pipeline report includes An overview of Nasal Polyps disease including symptoms, causes, diagnosis ...

January 2019 60 pages

2019 Future of Nasopharyngitis (Common Cold) R&D Pipeline Drugs and Companies- Analysis of Global Nasopharyngitis (Common Cold) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Nasopharyngitis (Common Cold) Report Description The H1 2019 pipeline review report on Nasopharyngitis (Common Cold) pipeline is a comprehensive ... detailed analysis on all active Nasopharyngitis (Common Cold) pipeline compounds. The Nasopharyngitis (Common Cold) pipeline guide presents ...

January 2019 40 pages

2019 Future of Otitis Media R&D Pipeline Drugs and Companies- Analysis of Global Otitis Media Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Otitis Media Report Description The H1 2019 pipeline review report on Otitis Media pipeline is a comprehensive study on the ... clear and actionable insights. Scope of Otitis Media pipeline report includes An overview of Otitis Media disease including symptoms, causes, diagnosis ...

January 2019 60 pages

2019 Future of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) R&D Pipeline Drugs and Companies- Analysis of Global Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... Phase 3 or Phase 4. Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Report Description The H1 2019 pipeline review report on Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD ...

January 2019 120 pages

2019 Future of Pressure Ulcers R&D Pipeline Drugs and Companies- Analysis of Global Pressure Ulcers Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Pressure Ulcers Report Description The H1 2019 pipeline review report on Pressure Ulcers pipeline is a comprehensive study on the ... and actionable insights. Scope of Pressure Ulcers pipeline report includes An overview of Pressure Ulcers disease including symptoms, causes, ...

January 2019 35 pages

2019 Future of Pruritus R&D Pipeline Drugs and Companies- Analysis of Global Pruritus Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Pruritus Report Description The H1 2019 pipeline review report on Pruritus pipeline is a comprehensive study on the candidates in development ...

January 2019 85 pages

2019 Future of Pulmonary Embolism R&D Pipeline Drugs and Companies- Analysis of Global Pulmonary Embolism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Pulmonary Embolism Report Description The H1 2019 pipeline review report on Pulmonary Embolism pipeline is a comprehensive study on ... and actionable insights. Scope of Pulmonary Embolism pipeline report includes An overview of Pulmonary Embolism disease including symptoms, causes, ...

January 2019 40 pages

2019 Future of Raynauds Disease R&D Pipeline Drugs and Companies- Analysis of Global Raynauds Disease Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Raynauds Disease Report Description The H1 2019 pipeline review report on Raynauds Disease pipeline is a comprehensive study on ... and actionable insights. Scope of Raynauds Disease pipeline report includes An overview of Raynauds Disease disease including symptoms, causes, diagnosis ...

January 2019 40 pages

2019 Future of Restenosis R&D Pipeline Drugs and Companies- Analysis of Global Restenosis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Restenosis Report Description The H1 2019 pipeline review report on Restenosis pipeline is a comprehensive study on the candidates in development ...

January 2019 45 pages

2019 Future of Rosacea R&D Pipeline Drugs and Companies- Analysis of Global Rosacea Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... of the Rosacea pipeline companies from advancing their products into Phase 3 or Phase 4. Rosacea Report Description The H1 2019 pipeline review ... report on Rosacea pipeline is a comprehensive study on the candidates ...

January 2019 60 pages

2019 Future of Scar R&D Pipeline Drugs and Companies- Analysis of Global Scar Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... of the Scar pipeline companies from advancing their products into Phase 3 or Phase 4. Scar Report Description The H1 2019 pipeline review ... report on Scar pipeline is a comprehensive study on the candidates ...

January 2019 75 pages

2019 Future of Secondary Hyperparathyroidism R&D Pipeline Drugs and Companies- Analysis of Global Secondary Hyperparathyroidism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Secondary Hyperparathyroidism Report Description The H1 2019 pipeline review report on Secondary Hyperparathyroidism pipeline is a comprehensive study on the candidates in development ...

January 2019 40 pages

2019 Future of Sinusitis R&D Pipeline Drugs and Companies- Analysis of Global Sinusitis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Sinusitis Report Description The H1 2019 pipeline review report on Sinusitis pipeline is a comprehensive study on the candidates in development ...

January 2019 75 pages

2019 Future of Thromboembolism R&D Pipeline Drugs and Companies- Analysis of Global Thromboembolism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Thromboembolism Report Description The H1 2019 pipeline review report on Thromboembolism pipeline is a comprehensive study on the candidates in development ...

January 2019 75 pages

Filters

Clear all